title: Factors affecting blood pressure responses to diet: the Vanguard study.
abstract: To study physiologic factors affecting the blood pressure (BP) response to nonpharmacologic maneuvers, fasting blood glucose, insulin, lipid and mineral levels, urinary mineral excretion, and the calcium regulating hormones parathyroid hormone (PTH) and 1,25 dihydroxyvitamin D (1,25 (OH)2D) were measured in 71 unmedicated hypertensive (26 hypertensive only [HT], 45 hypertensive hyperlipidemic [HTHL]), and 87 normotensive hyperlipidemic (NTHL) control subjects before and during a 10-week multicenter, randomized controlled trial comparing a prepared meal plan (CCNW) with a self-selected diet (SSD) based on nutritionist counseling. Blood pressure fell to a greater extent in hypertensive versus normotensive subjects (-8+/-1/-5+/-1 v -2+/-1/-2+/-1 mm Hg, P < .0001/P < .0001), and on CCNW versus SSD diets (delta systolic BP [SBP]/delta diastolic BP [DBP], P = .033/P = .002). Diet-induced weight change was the strongest correlate of changes in BP (SBP: r = 0.360, P < .0001; DBP: r = 0.414, P < .0001), which, on multivariate analysis for deltaSBP, could partly be accounted for by diet-induced changes in fasting glucose (r = 0.215, P = .009) and cholesterol (r = 0.219, P = .006) levels. Independently of weight, diet-induced changes in SBP also were significantly related to concomitant changes in urinary excretion of potassium (r = -0.285, P = .001), magnesium (r = -0.254, P = .003), and calcium relative to sodium (r = -0.200, P = .021), but not to sodium per se; and to changes in serum potassium (r = -0.249, P = .002), phosphorus (r = -0.279, P = .001), PTH (r = 0.288, P = .0006), and 1,25 D (r = 0.202, P = .017). We conclude that the ability of diet to lower BP successfully may result from the additive contributions of multiple components. Independently of weight loss and the associated changes in circulating glucose and cholesterol, BP is influenced by the increasing provision of minerals such as potassium, magnesium, and calcium, perhaps by virtue of their suppressive effects on circulating vasoactive calcium regulating hormones.
authors.affiliation: Hypertension Center, New York-Presbyterian Hospital/Cornell University Medical Center, New York 10021, USA.
authors.forename: L M
authors.initials: LM
authors.lastname: Resnick
authors.forename: S
authors.initials: S
authors.lastname: Oparil
authors.forename: A
authors.initials: A
authors.lastname: Chait
authors.forename: R B
authors.initials: RB
authors.lastname: Haynes
authors.forename: P
authors.initials: P
authors.lastname: Kris-Etherton
authors.forename: J S
authors.initials: JS
authors.lastname: Stern
authors.forename: S
authors.initials: S
authors.lastname: Clark
authors.forename: S
authors.initials: S
authors.lastname: Holcomb
authors.forename: D C
authors.initials: DC
authors.lastname: Hatton
authors.forename: J A
authors.initials: JA
authors.lastname: Metz
authors.forename: M
authors.initials: M
authors.lastname: McMahon
authors.forename: F X
authors.initials: FX
authors.lastname: Pi-Sunyer
authors.forename: D A
authors.initials: DA
authors.lastname: McCarron
mesh_terms: D000328:Adult; D001794:Blood Pressure; D002118:Calcium / Q000652:urine; D004032:Diet; D005260:Female; D006801:Humans; D006973:Hypertension / Q000178:diet therapy* / Q000503:physiopathology*; D008274:Magnesium / Q000652:urine; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011188:Potassium / Q000097:blood / Q000652:urine; D016032:Randomized Controlled Trials as Topic; D012016:Reference Values; D013599:Systole; D015431:Weight Loss
chemical_list: D008274:Magnesium; D011188:Potassium; D002118:Calcium